Methsuximide bulk supplier for pharma manufacturers

Methsuximide Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150 mg

Reference Brands: Celontin (USA)

Category: Neurology

Methsuximide is a succinimide anticonvulsant that helps reduce abnormal electrical activity in the brain. It is prescribed for controlling absence seizures when other medications fail to provide adequate seizure control. The drug works by raising the seizure threshold and modulating neuronal firing. It is typically used under specialist guidance and requires monitoring due to potential side effects such as drowsiness, dizziness, and gastrointestinal discomfort. Methsuximide is available in Capsules and strengths such as 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Methsuximide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Methsuximide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Methsuximide is used for the treatment of absence (petit mal) seizures, mainly in patients who do not respond adequately to first-line anticonvulsant medications.

Methsuximide is made from the active pharmaceutical ingredient methsuximide, a succinimide derivative that works by suppressing abnormal electrical activity in the brain.

The main trade name is Celontin.

Celontin has historically been marketed by major pharmaceutical companies in the United States. Manufacturers may vary depending on the region and availability.

The generic name is methsuximide.

The brand name is Celontin.

Methsuximide is manufactured by different pharmaceutical companies in various countries depending on brand ownership and regional regulatory approvals.

Yes, Methsuximide is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Methsuximide is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Donepezil Hydrochloride

Strength:
5 mg, 10 mg, 23 mg

Form: Tablets

Reference Brands: Aricept (USA/EU)

View Details
Acetazolamide Sodium

Strength:
125 mg, 250 mg, 500 mg,

Form: Tablets/ capsules/ Injectable

Reference Brands: Diamox (USA)

View Details
Rimegepant

Strength:
75 mg

Form: Tablets

Reference Brands: Nurtec ODT (USA), Vydura (EU)

View Details
Pimavanserin

Strength:
17 mg, 34 mg, 51 mg

Form: Tablets

Reference Brands: Nuplazid (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.